Postdoctoral Research Fellow

The Petitioner failed to show that his peer review work (2020-2022) or his publication and citation record set him apart from others in the field. The evidence did not establish the Petitioner as being in the upper echelon of the field despite meeting the minimum three-criteria threshold. Specific metrics for citations or publication counts were not detailed in the appellate dismissal.

The appeal was dismissed because the Petitioner failed to meet at least three of the ten EB-1A criteria. While she met the 'scholarly articles' criterion (publishing in The Journal of Allergy and Clinical Immunology and PLOS One), she did not provide sufficient evidence for 'awards' (a poster prize at EAACI lacked specific award details or criteria, and the RFE for primary evidence was not resolved) or 'original contributions of major significance' (52 cumulative citations across three articles were not shown to be unusually high for her field, and expert letters lacked specific corroborating details of major impact or widespread implementation). The AAO concluded she had not demonstrated sustained national or international acclaim.

The appeal was dismissed because the petitioner failed to meet the initial evidence requirements, specifically not demonstrating a major, internationally recognized award or satisfying at least three of the ten regulatory criteria. While two criteria (judging and scholarly articles) were met, the critical 'original contributions of major significance' criterion was not, as evidence like citation counts (e.g., top ten percent in Biology & Biochemistry) and recommendation letters lacked objective corroboration of widespread influence or significant impact on the field, and a Department of Defense funding grant was deemed for future research, not past recognition.